Compare PROF & TSSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PROF | TSSI |
|---|---|---|
| Founded | N/A | 2004 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.8M | 275.7M |
| IPO Year | 2017 | 2005 |
| Metric | PROF | TSSI |
|---|---|---|
| Price | $6.80 | $8.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $12.00 | ★ $16.00 |
| AVG Volume (30 Days) | 139.4K | ★ 845.6K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.89 | ★ 133.33 |
| EPS | N/A | ★ 0.13 |
| Revenue | $16,098,000.00 | ★ $245,719,000.00 |
| Revenue This Year | $92.40 | N/A |
| Revenue Next Year | $64.10 | $3.67 |
| P/E Ratio | ★ N/A | $67.62 |
| Revenue Growth | 50.73 | ★ 65.86 |
| 52 Week Low | $3.92 | $6.87 |
| 52 Week High | $8.95 | $21.77 |
| Indicator | PROF | TSSI |
|---|---|---|
| Relative Strength Index (RSI) | 44.69 | 37.01 |
| Support Level | $6.24 | $8.76 |
| Resistance Level | $7.03 | $10.02 |
| Average True Range (ATR) | 0.45 | 0.59 |
| MACD | -0.09 | -0.20 |
| Stochastic Oscillator | 14.57 | 7.18 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
TSS Inc provides a comprehensive suite of services for the integration of complex Artificial Intelligence (AI) technologies, planning, design, deployment, maintenance, and refresh of end-user and enterprise systems, including the mission-critical facilities that are housed. It provides a single-source solution for enabling technologies in data centers, operations centers, network facilities, server rooms, security operations centers, communications facilities, and the infrastructure systems that are critical to their functions. Services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services.